162 related articles for article (PubMed ID: 23535069)
1. The effects of Fasciola hepatica tegumental antigens on mast cell function.
Vukman KV; Adams PN; Dowling D; Metz M; Maurer M; O'Neill SM
Int J Parasitol; 2013 Jun; 43(7):531-9. PubMed ID: 23535069
[TBL] [Abstract][Full Text] [Related]
2. Fasciola hepatica tegumental coat impairs mast cells' ability to drive Th1 immune responses.
Vukman KV; Adams PN; Metz M; Maurer M; O'Neill SM
J Immunol; 2013 Mar; 190(6):2873-9. PubMed ID: 23418624
[TBL] [Abstract][Full Text] [Related]
3. Fasciola hepatica tegumental antigens indirectly induce an M2 macrophage-like phenotype in vivo.
Adams PN; Aldridge A; Vukman KV; Donnelly S; O'Neill SM
Parasite Immunol; 2014 Oct; 36(10):531-9. PubMed ID: 25039932
[TBL] [Abstract][Full Text] [Related]
4. Fasciola hepatica tegumental antigens induce anergic-like T cells via dendritic cells in a mannose receptor-dependent manner.
Aldridge A; O'Neill SM
Eur J Immunol; 2016 May; 46(5):1180-92. PubMed ID: 26931640
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica tegumental coat antigen suppresses MAPK signalling in dendritic cells and up-regulates the expression of SOCS3.
Vukman KV; Adams PN; O'Neill SM
Parasite Immunol; 2013 Jul; 35(7-8):234-8. PubMed ID: 23495757
[TBL] [Abstract][Full Text] [Related]
6. Liver fluke (Fasciola hepatica)-derived peptides activate rat peritoneal mast cells.
Trudgett A; Watt AP; Harriott P; Ennis M
Int Immunopharmacol; 2003 May; 3(5):775-81. PubMed ID: 12757746
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of dendritic cells pulsed with Fasciola hepatica antigens and lipopolysaccharides confers protection against fasciolosis in mice.
Falcón CR; Carranza FA; Aoki P; Motrán CC; Cervi L
J Infect Dis; 2012 Feb; 205(3):506-14. PubMed ID: 21949043
[TBL] [Abstract][Full Text] [Related]
8. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function.
Hamilton CM; Dowling DJ; Loscher CE; Morphew RM; Brophy PM; O'Neill SM
Infect Immun; 2009 Jun; 77(6):2488-98. PubMed ID: 19332532
[TBL] [Abstract][Full Text] [Related]
9. Fasciola hepatica: studies on vaccination of rats and mice with a surface antigen prepared from fluke homogenate by means of a monoclonal antibody.
Hanna RE; Anderson A; Trudgett AG
Res Vet Sci; 1988 Mar; 44(2):237-41. PubMed ID: 3291030
[TBL] [Abstract][Full Text] [Related]
10. Use of immunosorbent-purified antigens of Fasciola hepatica in enzyme immunoassays.
Trudgett A; Anderson A; Hanna RE
Res Vet Sci; 1988 Mar; 44(2):262-3. PubMed ID: 3291031
[TBL] [Abstract][Full Text] [Related]
11. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep.
Zhang WY; Moreau E; Hope JC; Howard CJ; Huang WY; Chauvin A
Exp Parasitol; 2005 Nov; 111(3):154-9. PubMed ID: 16126202
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils Control Liver Damage by Modulating Immune Responses Against
Frigerio S; da Costa V; Costa M; Festari MF; Landeira M; Rodríguez-Zraquia SA; Härtel S; Toledo J; Freire T
Front Immunol; 2020; 11():579801. PubMed ID: 33042162
[TBL] [Abstract][Full Text] [Related]
13. Cloning and sequence analysis of genes encoding Fasciola hepatica immunodominant antigens.
Mohamed MM; Al-Sherbiny MM; Araf AA; Elmamlouk TH
J Egypt Soc Parasitol; 2004 Dec; 34(3):819-40. PubMed ID: 15587310
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory Effect of Fasciola hepatica Excretory-Secretory Products on Macrophages.
Guasconi L; Serradell MC; Masih DT; Chiapello LS
Methods Mol Biol; 2020; 2137():117-131. PubMed ID: 32399925
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica Surface Coat Glycoproteins Contain Mannosylated and Phosphorylated N-glycans and Exhibit Immune Modulatory Properties Independent of the Mannose Receptor.
Ravidà A; Aldridge AM; Driessen NN; Heus FA; Hokke CH; O'Neill SM
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004601. PubMed ID: 27104959
[TBL] [Abstract][Full Text] [Related]
16. Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats.
van Milligen FJ; Cornelissen JB; Bokhout BA
Exp Parasitol; 2000 Mar; 94(3):163-71. PubMed ID: 10831381
[TBL] [Abstract][Full Text] [Related]
17. Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells.
Falcón C; Carranza F; Martínez FF; Knubel CP; Masih DT; Motrán CC; Cervi L
Vet Immunol Immunopathol; 2010 Sep; 137(1-2):36-46. PubMed ID: 20447697
[TBL] [Abstract][Full Text] [Related]
18. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice.
Espino AM; Osuna A; Gil R; Hillyer GV
Exp Parasitol; 2005 Aug; 110(4):374-83. PubMed ID: 15907838
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil differentiation in response to Fasciola hepatica and its excretory/secretory antigens.
Milbourne EA; Howell MJ
Int J Parasitol; 1993 Dec; 23(8):1005-9. PubMed ID: 8300295
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Immune Regulatory Properties of Dendritic Cells During Fasciola hepatica Infection.
Freire T
Methods Mol Biol; 2020; 2137():181-190. PubMed ID: 32399929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
